目的采用稀释血浆凝血酶时间法（稀释纠正法）检测血浆中特异性凝血酶抑制物，为抗血栓形成治疗提供有效的实验室监测试验。
Objective To detect specific thrombin inhibitors with a plasma diluted thrombin time and find an effective method for laboratory monitor of anticoagulant and thrombolytic therapy.
对血小板粘附、血栓形成有明显抑制作用，而对凝血酶凝血时间、血浆凝固时间无明显影响。
Tetrandrine also markedly inhibited platelet adhesion and thrombosis, but didn't change thrombin coagulation time and plasma coagulation time obviously.
分别测定血浆凝血酶原时间（PT）、活化部分凝血酶原时间（APTT）、凝血酶时间（TT），纤维蛋白原（FIB）、血清空腹血糖（GLU）水平。
Plasma prothrombin time (PT), activate part plasma prothrombin time (APTT), prothrombin time (TT) , fibrinogen (FIB) the level of fasting blood glucose (GLU) are tested separately.
发现怀牛膝多糖a BP能延长小鼠凝血时间(CT)、大鼠血浆凝血酶原时间(PT)、白陶土部分凝血活酶时间(KPTT)。
We found ABP prolonged coagulation time (CT) in mice, increased plasma prothrombin time (PT) and kaolin partial thromboplastin time (KPTT) in rats.
目的研究几种常见的癌症患者血浆凝血酶原时间（PT）、凝血酶时间（TT）、活化部分凝血酶时间（APTT）、纤维蛋白原（FIB）测定的临床价值。
Objective To study the clinical value of detecting several common cancer patients' protothrombin time(PT), thrombin time (TT), active part thrombin time(APTT) and fibrinogen(FIB).
目的研究几种常见的癌症患者血浆凝血酶原时间（PT）、凝血酶时间（TT）、活化部分凝血酶时间（APTT）、纤维蛋白原（FIB）测定的临床价值。
Objective To study the clinical value of detecting several common cancer patients' protothrombin time(PT), thrombin time (TT), active part thrombin time(APTT) and fibrinogen(FIB).
应用推荐